Loading...

Question

Case Scenario Eve

D‌‍‍‌‌‍‌‌‌‌‌‍‍‍‌‌‌‌‍irections:Please answer all the following questions and provide scholarly support.Your responses should be written in APA format. Questions - Make a diagnosis (and mention possible diagnoses/diagnoses to rule out) and explain the rationale for the diagnosis. What are the points in favor of a bipolar II diagnosis? What might account for the failure to respond to any of the prior treatments? Given the diagnosis you have made, describe your medication treatment strategies. Discuss not only initial choices of medications but also your next-step strategy and why you’ve chosen it. (In doing so, be sure to provide a rationale for your choices.) What questions should be addressed about the class of medications that is chosen (e.g., mood stabilizers)? Include a brief discussion of how you will integrate legal and ethical considerations of diagnosis, treatment, and consultation with medical professionals in light of the role and activities of the DEA. Readings: Week 2 Readings: Handbook of Clinical Psychopharmacology for Therapists Ninth Edition by John D. Preston PsyD ABPP (Author), John H. O'Neal MD (Author), Mary C. Talaga RPh PhD (Author), Bret A. Moore PsyD ABPP (Author) Chapter 16: Antidepressant Medications Chapter 17: Bipolar Medications Chapter 18: Antianxiety Medic‌‍‍‌‌‍‌‌‌‌‌‍‍‍‌‌‌‌‍ations Chapter 19: Antipsychotic Medications Readings in the DSM-5 - Depressive Disorders through Specifiers for Depressive Disorders. Pp. 155-188. Bipolar and Related Disorders. pp.123-154 Anxiety Disorders through Unspecified Obsessive-Compulsive and Related Disorder. pp. 189-264. Schizophrenia Spectrum and Other Psychotic Disorders through Unspecified Schizophrenia Spectrum and Other Psychotic Disorder. pp. 87-122. Articles- Sugarman, M. A. (2016). Are antidepressants and psychotherapy equally effective in treating depression? A critical commentary. Journal of Mental Health 25(6). 475-478. doi: 10.3109/09638237.2016.1139071 Haller, M., Myers, S., McKnight, A., Angkaw, A. C., Norman, S. B. (2016). Predicting engagement in psychotherapy, pharmacotherapy, or both psychotherapy and pharmacotherapy among returning veterans seeking PTSD treatment. Psychological Services 13(4). 341-348. doi: 10.1037/ser0000093 Please note if you can't access the Haller article you can use this one instead: Rauch SAM, Kim HM, Powell C, et al. Efficacy of Prolonged Exposure Therapy, Sertraline Hydrochloride, and Their Combination Among Combat Veterans

Expert Solution

Based on Eve’s clinical presentation, which included a family history of psychiatric problems, recurrent depressive episodes, and inadequate response to various antidepressants, suggests bipolar spectrum type II disorder. This diagnosis is characterized by cycles of hypomanic and depressive episodes (Haller et al., 2016). Although Eve's depressive symptoms are prominent, the lack of response to multiple antidepressants suggests an underlying bipolar component. It is crucial to distinguish this from unipolar major depressive disorder due to the repetitive nature of her depressive episodes. The initial episodes, triggered by relationship issues, differ from subsequent occurrences that appear to arise without identifiable psychosocial stressors. This precise diagnostic distinction emphasizes the complexity of Eve's condition and underscores the importance of a comprehensive evaluation (Sugarman, 2016). Thus, considering Bipolar II disorder as a potential diagnosis informs treatment decisions, necessitating the use of mood stabilizers instead of traditional antidepressants to address both depressive and potential hypomanic states effectively.

This question has been solved!

  • Verified by Admin
  • Written by a Human Expert
Blurred answer